AMR Industry Alliance 2020 Progress Report

Related Posts

• Joint Press Statement of European Pharmaceutical Industry… 11 December 2020
• New report assesses progress on biosimilar medicine policies… 29 March 2021 Biosimilar medicines are increasingly relevant to public health as emphasised by the…
• Review of the SPC Manufacturing Waiver: a First Industry… 13 June 2023 The Supplementary Protection Certificate (SPC) is a sui generis protection…
• New report reveals need for pricing and reimbursement and… 1 March 2021